Literature DB >> 30567258

Haemostatic radiation therapy for a bleeding intraductal papillary neoplasm of the biliary tree.

Senthil Sundaravadanan1, Manu Mathew2, Thomas Samuel Ram2, Philip Joseph1.   

Abstract

Haemostatic radiation was effectively used as a novel rescue therapy in a 60-year-old man who presented with recurrent melaena refractory to all conventional medical and surgical measures. He needed multiple transfusions and was diagnosed to be bleeding from an intraductal papillary biliary neoplasm which was not amenable to surgical resection in view of the background liver disease. He received conventional radiation therapy (RT) of a dose of 3 Gy per fraction for 3 consecutive days after which he stabilised. After cessation of the RT, he did not require transfusion for the next 2 months. His quality of life improved and it gave us time to evaluate for other definitive measures. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cirrhosis; radiotherapy; surgical oncology

Mesh:

Substances:

Year:  2018        PMID: 30567258      PMCID: PMC6301658          DOI: 10.1136/bcr-2018-226237

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  25 in total

1.  The clinicopathological features of intraductal papillary neoplasms of the bile duct in a Chinese population.

Authors:  Jian Yang; Wentao Wang; Lunan Yan
Journal:  Dig Liver Dis       Date:  2011-09-17       Impact factor: 4.088

Review 2.  Management of bleeding in patients with advanced cancer.

Authors:  Jose Pereira; Tien Phan
Journal:  Oncologist       Date:  2004

3.  The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.

Authors:  Jeremy Tey; Michael F Back; Thomas P Shakespeare; Rahul K Mukherjee; Jiade J Lu; Khai Mun Lee; Lea Choung Wong; Cheng Nang Leong; Ming Zhu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-21       Impact factor: 7.038

4.  Mucin-producing cholangiocarcinoma: clinical experience of 24 cases in 16 years.

Authors:  Chung-Mou Kuo; Chi-Sin Changchien; Keng-Liang Wu; Seng-Kee Chuah; King-Wah Chiu; Yi-Chun Chiu; Yeh-Pin Chou; Chung-Huang Kuo
Journal:  Scand J Gastroenterol       Date:  2005-04       Impact factor: 2.423

5.  Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype.

Authors:  Kwang Min Kim; Jong Kyun Lee; Jae Uk Shin; Kwang Hyuck Lee; Kyu Taek Lee; Ji-Youn Sung; Kee-Taek Jang; Jin Seok Heo; Seong-Ho Choi; Dong Wook Choi; Jae Hoon Lim
Journal:  Am J Gastroenterol       Date:  2011-09-27       Impact factor: 10.864

6.  Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?

Authors:  Flavio G Rocha; Hwajeong Lee; Nora Katabi; Ronald P DeMatteo; Yuman Fong; Michael I D'Angelica; Peter J Allen; David S Klimstra; William R Jarnagin
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

7.  Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas.

Authors:  H J Kim; M H Kim; S K Lee; K S Yoo; E T Park; B C Lim; H J Park; S J Myung; D W Seo; Y I Min
Journal:  Endoscopy       Date:  2000-05       Impact factor: 10.093

8.  Hemostatic radiotherapy in carcinoma of the uterine cervix.

Authors:  B M Biswal; P Lal; G K Rath; B K Mohanti
Journal:  Int J Gynaecol Obstet       Date:  1995-09       Impact factor: 3.561

9.  Palliative prostate radiotherapy for symptomatic advanced prostate cancer.

Authors:  Omar S Din; Narottam Thanvi; Catherine J Ferguson; Peter Kirkbride
Journal:  Radiother Oncol       Date:  2009-05-21       Impact factor: 6.280

10.  High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.

Authors:  Peter J Hoskin; Sandra M de Canha; Peter Bownes; Linda Bryant; Rob Glynne Jones
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.